Why did BIOFILCHEM.NS stock drop sharply on 05 Feb 2026?

BIOFILCHEM.NS stock fell due to heavy intraday selling, a volume spike to **115,236** shares, and renewed investor concern about very high receivables (DSO ~**350** days) that raise liquidity questions.

What are the key support and resistance levels for BIOFILCHEM.NS stock?

Immediate support is the year low **INR 28.50** and a short-term floor near **INR 29.00**. Resistance sits at the 200-day average **INR 41.37** and the prior close **INR 46.34**.

How does Meyka AI view BIOFILCHEM.NS stock and what is the forecast?

Meyka AI rates BIOFILCHEM.NS **62.79 (Grade B, HOLD)**. Forecasts project **monthly INR 29.29**, **quarterly INR 20.98**, and **yearly INR 18.58**. Forecasts are model-based and not guarantees.

Which metrics should investors monitor after the drop in BIOFILCHEM.NS stock?

Monitor days sales outstanding, receivables turnover, quarterly cash flow, and volume patterns. Also watch management commentary on collections and job-work orders to assess recovery prospects.

IN Stocks

BIOFILCHEM.NS (Biofil Chemicals) falls 18.99% to INR 37.54 on 05 Feb 2026 (NSE): watch liquidity and support near INR 28.50

ByDanny Kontos February 5, 2026

BIOFILCHEM.NS stock closed as a top loser on 05 Feb 2026 after plunging 18.99% to INR 37.54 on the NSE. Volume jumped to 115,236 shares versus an average of 38,098, signalling one-sided selling into the close. Intraday high was INR 40.37 and the stock opened at INR 40.37 after a previous close of INR 46.34. We view the drop as a liquidity-driven move layered on valuation worries and stretched receivables; Meyka AI’s analysis flags near-term downside to model support levels and elevated volatility for traders and investors.